FDA Inspection
Ingenus Pharmaceuticals GmbHIngenus Pharmaceuticals GmbH – FDA Inspection, Oct 31, 2017
Record Details
This FDA Inspection record concerns Ingenus Pharmaceuticals GmbH, with an inspection on October 31, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8c8bead2-8a44-454f-86a5-e331f7849dd1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1034770
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Ingenus Pharmaceuticals GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 3, 2024 | Not classified | Office of Inspections and Investigations | |
| December 3, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 11, 2018 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| November 4, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ingenus Pharmaceuticals GmbH
- FDA Inspection 1263921 - 2024-10-03
- FDA Inspection 1115845 - 2019-12-03
- FDA Inspection 1074093 - 2018-12-11
- FDA Inspection 905257 - 2014-11-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.